Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001548186 | SCV001768053 | likely benign | not provided | 2020-09-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001548186 | SCV002386539 | benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501885 | SCV002804443 | likely benign | Schinzel-Giedion syndrome; Intellectual disability, autosomal dominant 29 | 2022-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039288 | SCV004946255 | likely benign | Inborn genetic diseases | 2023-11-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004734228 | SCV005346109 | likely benign | SETBP1-related disorder | 2024-08-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |